. MCM2-7 were cloned into pGADT7 and introduced to AH109 strain in the presence or absence of a pBGKT7 plasmid expressing the indicated Mcm10 alleles. Yeast two hybrids were carried out as in Table S1 . Full-length of MCM2 (A) or its N-terminal fragment (B) was cloned into pGADT7 and introduced to AH109 strain in the presence or absence of a pBGKT7 plasmid expressing the indicated Mcm10 alleles.
Yeast two hybrids were carried out as in Table S1 . Cells were synchronized by addition of 7.5 μg/ml of α factor. G1 arrested cells were released by filter washing twice in fresh SC-His medium and continued growth for the indicated time. 
Supplemental Experimental Procedures

Strains and plasmids
Strains and plasmids used in this study are listed in Supplemental Table S2 -S3. Mutants were generated using recombination-mediated cassette exchange (Longtine et al., 1998) or tetrad dissection as previously described . All constructs were confirmed by DNA sequencing.
Cell synchronization and flow cytometry analysis
7.5 μg/ml of α factor was added for cell synchronization in G1-phase. G1 arrested cells were released by filter washing twice in fresh medium and continued growth for the indicated time. Samples were collected and fixed with 70% ethanol and then processed for flow cytometry using a BD Biosciences
FACSVerse machine. 
Whole cell extracts (WCE) and immunoblotting (IB)
WCE
Immunoprecipitation (IP)
IP analysis was performed using strains co-expressing the tagged versions of each protein at physiological level as indicated in each figure. IP was carried out basically as described previously . Input (IN) corresponding to approximately 100 μg total protein, were analyzed in parallel with immunoprecipitates (IP). Proteins were analyzed by mass spectrometry or western blotting using indicated antibodies.
Large scale native chromatin fractionation
The large scale native chromatin fraction was prepared essentially as described (Liang and Stillman, 1997; Sheu and Stillman, 2006) with minor modifications. Briefly, cells (strains QY6129, QY6131) of 150 OD600 units were spheroplasted by incubation with 50 U/ml lyticase (Sigma). Crude extract was prepared by Triton X-100 treatment and fractionized via sucrose cushion in 500 μl of the modified EBX-1 buffer {50 mM HEPES/KOH pH7.5, 150 mM KGlu, 2.5 mM MgOAc, 0.1 mM ZnOAc, 2 mM NaF, 0.5 mM spermidine, 20 mM -Glycerophosphate, 3 mM ATP, 1 mM DTT, 1 mM PMSF, Protease inhibitor tablets (EDTA free, Roche)}. The supernatant (SN1) contains non-chromatin bound proteins, while the chromatin is in the pellet. Chromatin-bound proteins (SN2) were released by rotation the pellet with EBX-1 buffer supplemented with 200 U/ml of Benzonase (Sigma) and 3 mM ATP for 30 min at 4°C. 
Sucrose gradient centrifugation
Two litres of G1 or S phase yeast cells (4×10 7 cells/ml) were fractionated as illustrated in Figure 1A by using the EBX-3 buffer {50 mM HEPES/KOH pH7.5, 150 mM KGlu, 2.5 mM MgOAc, 0.1 mM ZnOAc, 2 mM NaF, 0.5 mM spermidine, 20 mM -Glycerophosphate, 3 mM ATP, 1 mM DTT, 1 mM PMSF, Protease inhibitor tablets (EDTA free, Roche)}. 10 ml of SN1 or SN2 was mixed with 250 μl M2 beads for 3h with rotation at 4°C, and washed three times with 5 ml EBX-3 buffer. The bound fraction was eluted 300 μl of 2 μg/μl FLAG peptide. The 600 μl SN1 or SN2 FLAG elution was applied to a 5-30% sucrose gradient in buffer EBX-3. The samples were then centrifuged at 100,000g
for 5 h in a SW55 Ti rotor (Beckman Coulter). After centrifugation, the fractions (400 μl each) were collected from the top of the gradient and subjected to SDS-PAGE and immunoblots. Aldlase (158 kDa) and thyroglobulin (669 kDa) were used as size makers.
Protein expression, purification
Full length and truncated forms of pGEX4T-1-MCM10, pGEX-4T-1-mcm6(1-439), pGEX-4T-1-mcm4(1-471), pET28a-MCM10, pET28a-MCM2, pET28a-mcm2(1-299) constructs used in the biochemical experiments were expressed in E. coli BL21 (DE3) RIL codon-plus (Stratagene) and purified by affinity tags and conventional column chromatography.
Preparation of antibodies and Mcm10 agarose beads
To raise polyclonal antibody specific to Mcm10 or Mcm2, purified full-length protein was used to immunize rabbits. Polyclonal antibodies were affinity purified. Mcm10 beads were prepared by immobilize purified Mcm10 protein to NHS-activated agarose beads as recommended by the manufacturer (GE Healthcare), which was used for efficient in vitro pull-down assay.
In vitro pull-down assay
Approximately ten picomoles of each protein were mixed with glutathione-Sepharose 4B (GE Healthcare Life Sciences) or anti-Mcm10 agarosebeads made in this study were mixed in 100 μl of binding buffer (50 mM HEPES-NaOH pH 7.6, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM PMSF, 1 μg/μl BSA, and 0.1% Triton X-100) and incubated for 1 h at 4°C. The beads were washed at least three times prior to Western blotting and/or Coomassie staining.
Construction of mcm10 alleles
Viability of various mcm10 alleles was determined by plasmid shuffling since MCM10 is an essential gene. Wild type MCM10 was cloned and expressed in pRS316/URA3 vector to allow mcm10Δ mutants grow. pRS316-MCM10 plasmid was removed on 5-FOA plates due to its expression of URA3, which caused cells toxic to 5-FOA. The ability to support cell growth was tested for various mcm10 alleles expressed in pRS313/HIS3 vector under a range of genetic background as indicated in each figure.
5-fold serial dilution of log phase cells were spotted on SC-His plates in the presence or absence of 5-FOA and incubated for 2 days at indicated temperature before photographed.
